RAFF BERYL
RAFF BERYL's purchase track record
RAFF BERYL has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/14/2022 | ASO | $113 | -4.3% | +11.8% | -16.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Academy Sports Gets Telsey Reaffirmation Amid HOKA Focus. Telsey Advisory Group reaffirmed its Outperform rating on Academy Sports, prompting analysts to debate if the stock remains undervalued. Recent commentary also highlights the excitement around the HOKA brand, though some investors urge caution in interpreting these signals. The company trades at a P/E of 8.3, which is below the average analyst target of $58.84.
Transaction History
| HELE | ▲ Buy | Grant | 860 | $0 | 9/1/2026 | View on chart |
| ASO | ▲ Buy | Option Exercise | 3,932 | — | 6/3/2026 | View on chart |
| HELE | ▲ Buy | Grant | 919 | $0 | 6/1/2026 | View on chart |
| HELE | ▲ Buy | Grant | 1,429 | $0 | 3/2/2026 | View on chart |
| HELE | ▲ Buy | Grant | 1,253 | $0 | 12/1/2025 | View on chart |
| HELE | ▲ Buy | Grant | 992 | $0 | 9/2/2025 | View on chart |
| ASO | ▲ Buy | Option Exercise | 2,929 | — | 6/4/2025 | View on chart |
| HELE | ▲ Buy | Grant | 933 | $0 | 6/2/2025 | View on chart |
| HELE | ▲ Buy | Grant | 457 | $0 | 3/3/2025 | View on chart |
| HELE | ▲ Buy | Grant | 333 | $0 | 12/2/2024 | View on chart |
| HELE | ▲ Buy | Grant | 458 | $0 | 9/3/2024 | View on chart |
| ASO | ▲ Buy | Option Exercise | 2,861 | — | 6/3/2024 | View on chart |
| HELE | ▲ Buy | Grant | 231 | $0 | 6/3/2024 | View on chart |
| HELE | ▲ Buy | Grant | 197 | $0 | 3/1/2024 | View on chart |
| HELE | ▲ Buy | Grant | 223 | $0 | 12/1/2023 | View on chart |
| HELE | ▲ Buy | Grant | 201 | $0 | 9/1/2023 | View on chart |
| ASO | ▼ Sell | Gift | 30 | $0 | 6/20/2023 | View on chart |
| HELE | ▲ Buy | Grant | 261 | $0 | 6/1/2023 | View on chart |
| ASO | ▲ Buy | Option Exercise | 26 | — | 5/31/2023 | View on chart |
| ASO | ▲ Buy | Option Exercise | 4,334 | — | 5/31/2023 | View on chart |
| HELE | ▲ Buy | Grant | 222 | $0 | 3/1/2023 | View on chart |
| HELE | ▲ Buy | Grant | 242 | $0 | 12/1/2022 | View on chart |
| HELE | ▲ Buy | Grant | 196 | $0 | 9/1/2022 | View on chart |
| ASO | ▲ Buy | Option Exercise | 3,727 | — | 6/1/2022 | View on chart |
| HELE | ▲ Buy | Grant | 127 | $0 | 6/1/2022 | View on chart |
| ASO | ▲ Buy | Open Market | 3 | $113 | 4/14/2022 | View on chart |
| HELE | ▲ Buy | Grant | 121 | $0 | 3/1/2022 | View on chart |
| HELE | ▲ Buy | Grant | 97 | $0 | 12/1/2021 | View on chart |
| HELE | ▲ Buy | Grant | 97 | $0 | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
HELE Q2 Earnings Beat Estimates, Guidance Raised
Helen of Troy reported second‑quarter results that topped analysts’ expectations, driven by higher margins. The company also lifted its outlook for the coming period. Analysts note the stock may benefit from lower U.S.–China tariffs on consumer electronics, and UBS raised its price target while keeping a neutral stance. These points add to recent commentary describing the stock as attractively priced.
HELE Q2 Earnings Beat Estimates, Guidance Raised. Helen of Troy reported second‑quarter results that topped analysts’ expectations, driven by higher margins. The company also lifted its outlook for the coming period. Analysts note the stock may benefit from lower U.S.–China tariffs on consumer electronics, and UBS raised its price target while keeping a neutral stance. These points add to recent commentary describing the stock as attractively priced.